Legend Biotech (LEGN) Return on Equity (2020 - 2025)
Historic Return on Equity for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 0.21%.
- Legend Biotech's Return on Equity fell 1500.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.14% for FY2024, which is 1400.0% down from last year.
- As of Q3 2025, Legend Biotech's Return on Equity stood at 0.21%, which was down 1500.0% from 0.29% recorded in Q2 2025.
- Over the past 5 years, Legend Biotech's Return on Equity peaked at 0.02% during Q2 2024, and registered a low of 1711.13% during Q2 2021.
- Moreover, its 5-year median value for Return on Equity was 0.33% (2023), whereas its average is 107.66%.
- In the last 5 years, Legend Biotech's Return on Equity soared by 8373100bps in 2021 and then tumbled by -2700bps in 2025.
- Legend Biotech's Return on Equity (Quarter) stood at 1.25% in 2021, then skyrocketed by 31bps to 0.87% in 2022, then skyrocketed by 67bps to 0.29% in 2023, then soared by 89bps to 0.03% in 2024, then plummeted by -583bps to 0.21% in 2025.
- Its last three reported values are 0.21% in Q3 2025, 0.29% for Q2 2025, and 0.19% during Q1 2025.